Italy Biochip Market Size & Outlook, 2024-2030
Italy biochip market, 2018-2030 (US$M)
Related Markets
Italy biochip market highlights
- The Italy biochip market generated a revenue of USD 244.5 million in 2023 and is expected to reach USD 522.6 million by 2030.
- The Italy market is expected to grow at a CAGR of 11.5% from 2024 to 2030.
- In terms of segment, dna chips was the largest revenue generating type in 2023.
- Lab-on-chip is the most lucrative type segment registering the fastest growth during the forecast period.
Biochip market data book summary
| Market revenue in 2023 | USD 244.5 million |
| Market revenue in 2030 | USD 522.6 million |
| Growth rate | 11.5% (CAGR from 2023 to 2030) |
| Largest segment | Dna chips |
| Fastest growing segment | Lab-on-chip |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Tissue Arrays, Cell Arrays, DNA Chips, Lab-on-chip, Protein Chips |
| Key market players worldwide | Agilent Technologies Inc, PerkinElmer, Illumina Inc, Bio-Rad Laboratories Inc, Standard BioTools Inc, GE HealthCare Technologies Inc Common Stock, Thermo Fisher Scientific Inc, Qiagen NV, Randox |
Other key industry trends
- In terms of revenue, Italy accounted for 2.2% of the global biochip market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany biochip market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 2,058.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Biochip Market Scope
Biochip Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Italy biochip market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biochip market will help companies and investors design strategic landscapes.
Dna chips was the largest segment with a revenue share of 38.85% in 2024. Horizon Databook has segmented the Italy biochip market based on tissue arrays, cell arrays, dna chips, lab-on-chip, protein chips covering the revenue growth of each sub-segment from 2018 to 2030.
The biotechnology industry in Italy witnessed significant growth due to tremendous advancements in biomanufacturing and industrial research. The country hosts several biotechnology & biopharmaceutical hotspots and is home to several key players in the plasmid DNA manufacturing domain.
For instance, Milan is the hub of the biotechnology sector in Italy, housing approximately 35% of all biotech companies. In August 2022, the Lung Ambition Alliance—launched by the International Association for the Study of Lung Cancer, AstraZeneca, the Worldwide Lung Cancer Coalition, and Guardant Health—established the Lung Cancer Policy Network as a multistakeholder global project.
Guardant Health, AstraZeneca, Johnson & Johnson, and Medtronic provided funding for the initiative, which aimed at enhancing cancer screening in Italy. In the recent past, the Italian biotechnology industry has demonstrated notable growth due to major academic and industrial research.
Reasons to subscribe to Italy biochip market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Italy biochip market databook
-
Our clientele includes a mix of biochip market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy biochip market, including forecasts for subscribers. This country databook contains high-level insights into Italy biochip market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Italy biochips market size, by type, 2018-2030 (US$M)
Italy Biochip Market Share, 2024 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
